Heart failure experts at the National Research Center for Cardiac Surgery in Astana, Kazakhstan, recently announced the first successful implantation of the FIVAD (Fully Implanted Ventricular...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
-
-
This is an example of an arterial venous malformation (AVM) in the brain imaged on a ...
-
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufactured Dec.
-
Stroke survivors have better quality of life three months after their stroke if the clot that caused the stroke was mechanically removed even hours beyond the ideal treatment window compared to...
News | Stroke | February 15, 2019
February 15, 2019 — Corindus Vascular Robotics Inc. is seeking premarket clearance from the U.S. Food and Drug...
News | Structural Heart Occluders | February 13, 2019
February 13, 2019 — Le Bonheur Children's Hospital cardiologists in Memphis, Tenn., implanted the Amplatzer Piccolo...
News | Thrombectomy Devices | February 12, 2019
February 12, 2019 — A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology...
Videos | Angiography | February 08, 2019
This is an example of an arterial venous malformation (AVM) in the brain imaged on a ...
Technology | Stent Grafts | February 07, 2019
February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant...
Technology | Angiography | February 06, 2019
February 6, 2019 — Canon Medical Systems USA Inc. recently introduced a new...
Feature | Cath Lab | February 06, 2019
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters...
The Abiomed Impella RP had higher than expected mortality in its post-approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.
Feature | Hemodynamic Support Devices | February 05, 2019 | Dave Fornell, Editor
The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of...
Technology | Angiography | February 04, 2019
February 4, 2019 — Canon Medical Systems USA recently introduced its next generation of...
Two of the top news items from January included news atrial fibrillation guidelines that now recommend new anticoagulants (NOACs) over warfarin, and the FDA warning hospitals about the increased mortality found in one study involving pacitaxel-eluting stents and balloon devices for the peripheral arteries.
Feature | February 01, 2019 | Dave Fornell, Editor
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...
Technology | Hemostasis Management | February 01, 2019
February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now...
